Paper6202893
Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM and 5 others. J Urol, 1984. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Murine hybridoma antibodies against human transitional carcinoma-associated antigens. Papers, record 6202893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6202893
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| Antigens, Neoplasm | Major topic |
| Carcinoma, Transitional Cell | Major topic |
| Hybridomas | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Animals | |
| Cell Line | |
| Epitopes | |
| Humans | |
| Immunoenzyme Techniques | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA09120 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA12800 | NCI NIH HHS | United States | P01CA012800 | PubMed and NIH | NIH RePORTER |
| CA16880 | NCI NIH HHS | United States | R26CA016880 | PubMed and NIH | NIH RePORTER |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8071117 | Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/8071117 | PubMed |
| 4015953 | Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4015953 | PubMed |
| 3689660 | Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3689660 | PubMed |
| 3529570 | Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies. | Urol Res | 1986 | https://conductscience.org/library/papers/3529570 | PubMed |
| 3313389 | Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3313389 | PubMed |
| 2200496 | Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1. | Br J Cancer Suppl | 1990 | https://conductscience.org/library/papers/2200496 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6202893
GET https://conductscience.org/api/papers/v1/6202893/authors